Legal & General Group Plc

Position in CGON — CG Oncology, Inc.

CIK 764068 London, X0

Position in CGON

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$2,572,380

+$697,878 QoQ

Shares Held

38,008

-15.8% QoQ

Ownership

0.043%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Legal & General Group Plc holds $3,031,079,539 across 241 Biotechnology names. CGON ranks #62 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,955,764	$873,326,855
2	REGN	Regeneron Pharmaceuticals, Inc.	732,054	$565,614,201
3	ALNY	Alnylam Pharmaceuticals, Inc.	934,881	$309,324,075
4	RPRX	Royalty Pharma plc	3,362,872	$161,316,968
5	INCY	Incyte Corp	1,543,188	$145,244,853
6	INSM	INSMED Inc	787,079	$128,703,157
7	ARGX	Argenx SE	150,850	$110,158,211
8	MRNA	Moderna, Inc.	750,841	$38,142,721

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,572,380	38,008	-15.8%	Shares	Defined	2026-05-08
2025-12-31	$1,874,502	45,147	+4.4%	Shares	Defined	2026-02-09
2025-09-30	$1,741,626	43,238	-2.5%	Shares	Defined	2025-11-13
2025-06-30	$1,153,204	44,354	+12.3%	Shares	Defined	2025-08-12
2025-03-31	$967,525	39,507	+35.0%	Shares	Defined	2025-05-15
2024-12-31	$839,233	29,262	+19.9%	Shares	Defined	2025-02-13
2024-09-30	$920,497	24,397	+27.5%	Shares	Defined	2025-02-28
2024-06-30	$604,091	19,135	+785.1%	Shares	Defined	2025-05-29
2024-03-31	$94,911	2,162	—	Shares	Defined	2025-05-29
No filing history on record for this holder in this stock.